|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | IST Collaborative Group:Blood pressure and clinical outcomes in the International Stroke Trial显示文摘 | Bath PM Phillips S J | 2002 | Stroke2002，33，： | 1 |
| 2 | An in vivo comparison of the potential for extravertebral cement leak after vertebroplasty and kyphoplasty 显示文摘 | Phillips PM Wetzel Todd F Lieberman I | 2002 | Spine2002，27，19： | 1 |
| 3 | Blood pressure and clinical outcome in the international stroke trial显示文摘 | Leonardi-Bee J Bath PM Phillips SJ | 2002 | Stroke2002，33，： | 1 |
| 4 | Time-course, dose-response, and age comparative sensitivity of N-methyl carbamates in rats显示文摘 | Moser VC McDaniel KL Phillips PM | 2010 | Toxicol Sci2010，114，1： | 1 |
| 5 | The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis 显示文摘 | Steinbach G Lynch PM Phillips RK | 2000 | N Engl J Med2000，342，26： | 1 |
| 6 | The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis 显示文摘 | Steinbach G Lynchpm PM Phillips RK | 2000 | N Engl J Med2000，342，26： | 1 |
| 7 | Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancer显示文摘 | Connie PM Duong Jennifer A Westwood Linda J Berry Phillip K Darcy Michael H Kershaw | 2011 | Immunotherapy2011，，1： | 1 |
| 8 | A randomised,double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor,on duodenal polyposis in familial adenomatous polyposis显示文摘 | Phillips RK Wallace MH Lynch PM | 2002 | Gut2002，50，6： | 1 |
| 9 | Blood pressure and clinical outcomes in the intemation stroke trial显示文摘 | Leonardi-Bee J Bath PM Phillips SJ | 2002 | Stroke2002，33，： | 1 |
| 10 | The effect of celecoxib, a cyclooxgenase-2 inhibitor, in familial adenomatous polyposis显示文摘 | Steinbach G Lynch PM Phillips RK | 2000 | N Engl J Med2000，342，26： | 1 |
| 11 | A randomized, double blind, placebo controlled study of celecoxib, a selective cyclooxgenase-2 inhibitor, on duodenal polyposis in familial adenomatous polyposis显示文摘 | Phillips RK Wallace MH Lynch PM | 2002 | Gut2002，50，6： | 1 |
| 12 | Blood pressure andclinical outcomes in the International Stroke Trial 显示文摘 | Leonardi-Bee J Bath PM Phillips SJ | 2002 | Stroke2002，33，5： | 1 |
| 13 | Bloodpressure and clinical outcomes in the International Stroke Trial显示文摘 | Leonardi-Bee J Bath PM Phillips SJ | 2002 | Stroke2002，33，： | 1 |
| 14 | Blood pressure and clinical outcomes in the International Stroke Trial显示文摘 | Leonardi-Bee J Bath PM Phillips S J | 2002 | Stroke2002，33，5： | 1 |
| 15 | Understanding oral glucose tolerance; comparison of glucose or insulin measurements during the oral glucose tolerance tests with specific measurements of insulin resistance and secretion显示文摘 | Phillips DI Clark PM Osmond CN | 1994 | Diabet Med1994，11，： | 1 |
| 16 | Understanding oral glucose tolerance:comparison of glucose of insulin resistance and secretion显示文摘 | Phillips DI Clark PM Hales CN | 1994 | Diabet Med1994，11，3： | 1 |
| 17 | Blood pressure and clinical outcomes in the International stroke Trial显示文摘 | Leonardi-Bee J Bath PM Phillips SJ | 2002 | Stroke2002，33，5： | 1 |
| 18 | Blood pressure and clinical outcomes in the International Stroke Trial显示文摘 | Leonardi-Bee J Bath PM Phillips SJ | 2002 | Stroke2002，33，5： | 1 |
| 19 | Blood pressure and clinical outcomes in the International Stroke Trail 显示文摘 | Leonardi-Bee J Bath PM Phillips SJ | 2002 | Stroke2002，33，5： | 1 |
| 20 | Understanding oral glucose tolerance:comparison of glucose or insulin measure ments during the oral glucose tolerance tests with specific measurements of insulin resistance and secretion显示文摘 | Phillips DI Clark PM Osmond CN | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员